99 related articles for article (PubMed ID: 14991008)
21. Enhancement of immunity by a DNA melanoma vaccine against TRP2 with CCL21 as an adjuvant.
Yamano T; Kaneda Y; Huang S; Hiramatsu SH; Hoon DS
Mol Ther; 2006 Jan; 13(1):194-202. PubMed ID: 16112911
[TBL] [Abstract][Full Text] [Related]
22. TLR9 pathway is involved in adjuvant effects of plasmid DNA-based vaccines.
Tudor D; Dubuquoy C; Gaboriau V; Lefèvre F; Charley B; Riffault S
Vaccine; 2005 Jan; 23(10):1258-64. PubMed ID: 15652668
[TBL] [Abstract][Full Text] [Related]
23. Dendritic cell migration to peripheral lymph nodes.
Martín-Fontecha A; Lanzavecchia A; Sallusto F
Handb Exp Pharmacol; 2009; (188):31-49. PubMed ID: 19031020
[TBL] [Abstract][Full Text] [Related]
24. Adjuvant activity of CpG oligodeoxynucleotides.
Klinman DM
Int Rev Immunol; 2006; 25(3-4):135-54. PubMed ID: 16818369
[TBL] [Abstract][Full Text] [Related]
25. On immunostimulants and dendritic cell activation.
Sidoti Migliore G; Pezzino G; Cavaliere R; De Pasquale C; Ferlazzo G
Immunol Lett; 2021 Apr; 232():45-47. PubMed ID: 33609612
[No Abstract] [Full Text] [Related]
26. CCL19 (ELC) as an adjuvant for DNA vaccination: induction of a TH1-type T-cell response and enhancement of antitumor immunity.
Westermann J; Nguyen-Hoai T; Baldenhofer G; Höpken UE; Lipp M; Dörken B; Pezzutto A
Cancer Gene Ther; 2007 Jun; 14(6):523-32. PubMed ID: 17384577
[TBL] [Abstract][Full Text] [Related]
27. The effects of IL-6 and TNF-alpha as molecular adjuvants on immune responses to FMDV and maturation of dendritic cells by DNA vaccination.
Su B; Wang J; Wang X; Jin H; Zhao G; Ding Z; Kang Y; Wang B
Vaccine; 2008 Sep; 26(40):5111-22. PubMed ID: 18462845
[TBL] [Abstract][Full Text] [Related]
28. Multiple-site DNA vaccination enhances immune responses in mice.
Gardiner DF; Huang Y; Basu S; Leung L; Song Y; Chen Z; Ho DD
Vaccine; 2006 Jan; 24(3):287-92. PubMed ID: 16137804
[TBL] [Abstract][Full Text] [Related]
29. Pulmonary delivery of DNA encoding Mycobacterium tuberculosis latency antigen Rv1733c associated to PLGA-PEI nanoparticles enhances T cell responses in a DNA prime/protein boost vaccination regimen in mice.
Bivas-Benita M; Lin MY; Bal SM; van Meijgaarden KE; Franken KL; Friggen AH; Junginger HE; Borchard G; Klein MR; Ottenhoff TH
Vaccine; 2009 Jun; 27(30):4010-7. PubMed ID: 19389445
[TBL] [Abstract][Full Text] [Related]
30. Comparative evaluation of CD8+CTL responses following gene gun immunization targeting the skin with intracutaneous injection of antigen-transduced dendritic cells.
Gaffal E; Schweichel D; Tormo D; Steitz J; Lenz J; Basner-Tschakarjan E; Limmer A; Tüting T
Eur J Cell Biol; 2007 Dec; 86(11-12):817-26. PubMed ID: 16928407
[TBL] [Abstract][Full Text] [Related]
31. Comment on "Dendritic cells and monocyte/macrophages that create the IL-6/APRIL-rich lymph node microenvironment where plasmablasts mature".
Belnoue E; Matthes T; Siegrist CA; Huard B
J Immunol; 2009 May; 182(9):5159; author reply 5160. PubMed ID: 19380754
[No Abstract] [Full Text] [Related]
32. AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity.
Didierlaurent AM; Morel S; Lockman L; Giannini SL; Bisteau M; Carlsen H; Kielland A; Vosters O; Vanderheyde N; Schiavetti F; Larocque D; Van Mechelen M; Garçon N
J Immunol; 2009 Nov; 183(10):6186-97. PubMed ID: 19864596
[TBL] [Abstract][Full Text] [Related]
33. [Immune responses to pcDNA3.1 hisB-IL-15 and HBsAg DNA vaccine in BALB/c mice].
Yang CY; Su XS; Li MN; He Y
Zhonghua Gan Zang Bing Za Zhi; 2004 Dec; 12(12):758-9. PubMed ID: 15619350
[No Abstract] [Full Text] [Related]
34. Immunology: dangerous liaisons.
Heath WR; Carbone FR
Nature; 2003 Oct; 425(6957):460-1. PubMed ID: 14523425
[No Abstract] [Full Text] [Related]
35. Advances in the development of next-generation anthrax vaccines.
Friedlander AM; Little SF
Vaccine; 2009 Nov; 27 Suppl 4():D28-32. PubMed ID: 19837282
[TBL] [Abstract][Full Text] [Related]
36. The synthetic peptide Trp-Lys-Tyr-Met-Val-D-Met as a novel adjuvant for DNA vaccine.
Lee CG; Choi SY; Park SH; Park KS; Ryu SH; Sung YC
Vaccine; 2005 Sep; 23(38):4703-10. PubMed ID: 15936851
[TBL] [Abstract][Full Text] [Related]
37. DNA vaccines against cancer.
Stan R; Wolchok JD; Cohen AD
Hematol Oncol Clin North Am; 2006 Jun; 20(3):613-36. PubMed ID: 16762727
[TBL] [Abstract][Full Text] [Related]
38. Fusion of CpG-ODN-stimulating dendritic cells with Lewis lung cancer cells can enhance anti-tumor immune responses.
Du YC; Lin P; Zhang J; Lu YR; Ning QZ; Wang Q
Tissue Antigens; 2006 May; 67(5):368-76. PubMed ID: 16671943
[TBL] [Abstract][Full Text] [Related]
39. Limited amounts of dendritic cells migrate into the T-cell area of lymph nodes but have high immune activating potential in melanoma patients.
Verdijk P; Aarntzen EH; Lesterhuis WJ; Boullart AC; Kok E; van Rossum MM; Strijk S; Eijckeler F; Bonenkamp JJ; Jacobs JF; Blokx W; Vankrieken JH; Joosten I; Boerman OC; Oyen WJ; Adema G; Punt CJ; Figdor CG; de Vries IJ
Clin Cancer Res; 2009 Apr; 15(7):2531-40. PubMed ID: 19318472
[TBL] [Abstract][Full Text] [Related]
40. Are mineral adjuvants triggering TLR2/TLR4 on dendritic cells by a secondary cascade reaction in vivo through the action of heat shock proteins and danger signals?
Lindblad EB
Vaccine; 2006 Feb; 24(6):697-8. PubMed ID: 16129524
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
